Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gilead licenses Viread to eight generic companies
<p>The agreement gives the companies the rights to produce and distribute generic versions of tenofovir disoproxil fumarate to 95 low-income countries around the world, including India. Tenofovir DF
<p>The agreement gives the companies the rights to produce and distribute generic versions of tenofovir disoproxil fumarate to 95 low-income countries around the world, including India. Tenofovir DF
Xyzal is a replacement of UCB’s previous allergy drug, Zyrtec which will lose its patent in the US in 2007. In July 2006, UCB submitted a new drug
Lamictal is an anti-seizure medication that will now be used to treat Primary Generalized Tonic-Clonic (PGTC) seizures as a result of the approval. With this new indication, Lamictal
The program has opened in the US and will open shortly in Canada and Europe, subject to the necessary approvals. The program will provide access for HIV-1 infected
“Patient satisfaction is a critical component to infertility treatment success,” said Stephen Somkuti, the lead author and coordinating investigator from Abington Reproductive Medicine. “By providing products that patients
The drugs will be developed to enhance the restorative benefits derived from sleep and offset problems associated with sleep deprivation. Under the award, Lexicon will be investigating the
Canada-based pharmaceutical firm Anormed agreed to sell Fosrenol to Shire in 2004 in return for milestone payments after the drug was approved in relevant countries. The recent $3
Statistical significance was achieved on all three criteria defined in the Special Protocol Assessment by the FDA. A significantly greater proportion of people taking Fampridine-SR had a consistent
Gardasil prevents cervical cancer and vaginal and vulvar pre-cancers caused by the human papilloma virus (HPV). Gardasil is already approved in the United States for 9- to 26-year-old
Noxafil is an oral suspension product for the prevention of fungal infections in patients who are at high risk of developing these infections. The CHMP also recommended approval